142 related articles for article (PubMed ID: 3632912)
21. [VM-26 and cytosine arabinoside in the treatment of acute refractory lymphoblastic leukemia in adults].
Marín P; Grañena A; Carreras E; Sierra J; Olivé MT; Rozman C
Sangre (Barc); 1984; 29(4-A):399-404. PubMed ID: 6594782
[No Abstract] [Full Text] [Related]
22. Teniposide (VM-26) in patients with non-squamous-cell carcinoma of the cervix. A phase II trial of the Gynecologic Oncology Group.
Muss HB; Bundy BN; Given FT; Stehman FB
Am J Clin Oncol; 1990 Apr; 13(2):117-8. PubMed ID: 2316480
[TBL] [Abstract][Full Text] [Related]
23. Phase II study of VM-26 in adult malignancies.
Spremulli E; Schulz JJ; Speckhart VJ; Wampler GL
Cancer Treat Rep; 1980 Jan; 64(1):147-9. PubMed ID: 7379049
[No Abstract] [Full Text] [Related]
24. Teniposide in recurrent or advanced cervical carcinoma: a phase II trial in patients not previously treated with cytotoxic therapy.
Pfeiffer P; Cold S; Bertelsen K; Panduro J; Sandberg E; Rose C
Gynecol Oncol; 1990 May; 37(2):230-3. PubMed ID: 2344968
[TBL] [Abstract][Full Text] [Related]
25. Teniposide (VM-26) and cytosine arabinoside as consolidation therapy in adult high-risk patients with acute lymphoblastic leukemia.
Hoelzer D; Thiel E; Löffler H; Büchner T; Ganser A; Heil G; Kurrle E; Heimpel H; Koch P; Lipp T
Semin Oncol; 1987 Jun; 14(2 Suppl 1):92-7. PubMed ID: 3473688
[No Abstract] [Full Text] [Related]
26. Teniposide (VM-26) in patients with advanced refractory ovarian cancer: a phase II study of the Netherlands Joint Study Group for Ovarian Cancer.
van der Burg ME; ten Bokkel Huinink WW; Vriesendorp R; van Oosterom AT; Neijt JP; Vermorken JB; van Putten WL; Kooiman A
Eur J Cancer Clin Oncol; 1987 Jul; 23(7):997-8. PubMed ID: 3666002
[TBL] [Abstract][Full Text] [Related]
27. Phase II study of teniposide in small cell carcinoma of the lung.
Pedersen AG; Bork E; Osterlind K; Dombernowsky P; Hansen HH
Cancer Treat Rep; 1984 Oct; 68(10):1289-91. PubMed ID: 6098366
[TBL] [Abstract][Full Text] [Related]
28. [Results of a clinical study of an epipodophyllotoxin preparation (VM 26) in children with hemoblastoses].
Kondrat'eva NA; Makhonova LA; Maiakova SA; Vialushkin BIa
Probl Gematol Pereliv Krovi; 1981 Apr; 26(4):12-6. PubMed ID: 7015318
[No Abstract] [Full Text] [Related]
29. Phase II trial of teniposide in previously treated and untreated patients with advanced colorectal carcinoma: an Illinois Cancer Council Trial.
Locker GY; Lanzotti V; Khandekar JD; Sweet D; Shaw J; Bitran J; Gordon L; Krauss S; Johnson C
Cancer Treat Rep; 1986 Feb; 70(2):307-8. PubMed ID: 3948195
[No Abstract] [Full Text] [Related]
30. [Treatment of acute refractory lymphoblastic leukemia in the adult with VM-26 and ARA-C].
Rafecas FJ; Sanz MA
Sangre (Barc); 1984; 29(6):1052-3. PubMed ID: 6598235
[No Abstract] [Full Text] [Related]
31. Teniposide in the treatment of non-small cell lung carcinoma.
Giaccone G; Donadio M; Ferrati P; Bonardi G; Ciuffreda L; Bagatella M; Calciati A
Cancer Treat Rep; 1987 Jan; 71(1):83-5. PubMed ID: 3024829
[TBL] [Abstract][Full Text] [Related]
32. Teniposide (VM26) disposition in children with leukemia.
Sinkule JA; Stewart CF; Crom WR; Melton ET; Dahl GV; Evans WE
Cancer Res; 1984 Mar; 44(3):1235-7. PubMed ID: 6581866
[TBL] [Abstract][Full Text] [Related]
33. Phase II evaluation of VM-26 in patients with metastatic transitional cell carcinoma of the urinary tract: an Eastern Cooperative Oncology Group study.
Qazi R; Elson P; Khandekar JD
Cancer Treat Rep; 1982 Feb; 66(2):405-6. PubMed ID: 7055823
[No Abstract] [Full Text] [Related]
34. VM-26 and cytarabine combination chemotherapy in refractory or relapsed adult acute lymphoblastic leukemia.
Carella AM; Santini G; Martinengo M; Giordano D; Nati S; Congiu A; Risso M; Vimercati R; Cerri R; Rossi E
Haematologica; 1984; 69(6):747-51. PubMed ID: 6441752
[No Abstract] [Full Text] [Related]
35. Phase II study of teniposide (VM26) in cutaneous T-cell lymphomas.
Sorio R; Tirelli U; Zagonel V; Carbone A; Monfardini S
Am J Clin Oncol; 1990 Feb; 13(1):14-6. PubMed ID: 2305716
[TBL] [Abstract][Full Text] [Related]
36. Combined VM-26 and cytosine arabinoside in treatment of refractory childhood lymphocytic leukemia.
Rivera G; Aur RJ; Dahl GV; Pratt CB; Wood A; Avery TL
Cancer; 1980 Mar; 45(6):1284-8. PubMed ID: 7357520
[TBL] [Abstract][Full Text] [Related]
37. Phase I/pharmacokinetic study of intraperitoneal teniposide (VM 26).
Canal P; Bugat R; Chatelut E; Pinel MC; Houin G; Plusquellec Y; Carton M
Eur J Cancer Clin Oncol; 1989 May; 25(5):815-20. PubMed ID: 2737218
[TBL] [Abstract][Full Text] [Related]
38. Total-body irradiation and high-dose teniposide: a pilot study in bone marrow transplantation for patients with relapsed acute lymphoblastic leukemia.
Krance RA; Forman SJ; Blume KG
Cancer Treat Rep; 1987 Jun; 71(6):645-7. PubMed ID: 3555790
[TBL] [Abstract][Full Text] [Related]
39. VM26: phase I and II studies.
Macbeth FR
Cancer Chemother Pharmacol; 1982; 7(2-3):87-91. PubMed ID: 7044595
[No Abstract] [Full Text] [Related]
40. Teniposide in squamous cell carcinoma of the cervix: a phase II trial of the Gynecologic Oncology Group.
Muss HB; Bundy BN; Yazigi R; Yordan E
Cancer Treat Rep; 1987 Sep; 71(9):873-4. PubMed ID: 3621222
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]